Is There a Wegovy Payment Plan in the UK?

Why no formal payment plan exists, and what the monthly model actually means

The phrase "Wegovy payment plan" comes up a lot in searches, and it is a fair question to ask. Private healthcare in the UK rarely offers formal credit-based instalment plans for prescription medicines, partly because of how prescribing law works. Each prescription covers a defined supply period (usually four weeks) and must be reviewed before the next one is issued. That clinical checkpoint is a feature, not an inconvenience: it means the prescriber confirms treatment is still working and still safe before authorising more.

In practice, the monthly cycle functions like a natural payment rhythm. You pay for one period at a time, and you are not locked into a contract or an auto-renewal. Providers who review clinically before each repeat (rather than rolling a subscription forward automatically) give you a genuine stopping point each month if circumstances change. That is worth understanding before you begin. For a fuller picture of how treatment is structured, the Wegovy treatment plan overview explains what the journey looks like from first dose to maintenance.

One thing to be aware of: some providers do charge upfront fees on top of the medicine cost, including separate consultation fees or delivery charges. When you add those up across several months, the comparison shifts. A single transparent price per cycle is simpler to budget around.

The real cost question: NHS versus private, and what each involves

Wegovy is available on the NHS, but NICE's guidance (TA875) restricts it to adults with a BMI of 35 or above and at least one weight-related condition, receiving treatment within a specialist weight management service for a maximum of two years. Waiting times for those services are long in most parts of England, and Wegovy's private price has shifted over time as supply and demand have changed.

For people who do not meet NHS criteria or cannot wait, private treatment is the practical route. The context around Wegovy pricing in the UK sets out what the market looks like and why the lowest headline figure is not always the most useful comparison. The NHS guidance on weight management injections is a good starting point if you want to understand what NHS access involves and whether you might qualify.

For Scotland, Wales and Northern Ireland, eligibility thresholds and access pathways differ, if you are outside England it is worth checking with your GP practice about what applies locally.

What a legitimate private prescription for Wegovy actually costs you

When you pay for Wegovy through a regulated UK pharmacy, you are paying for more than the medicine itself. A legitimate prescription cycle should include the clinical assessment, the prescription itself, the medicine, and delivery. Some providers charge for each of those separately; others include everything in one figure. Splitting them out and adding them up before you decide is sensible budgeting.

The other dimension is aftercare. A medicine like semaglutide comes with a titration schedule (dose steps that a prescriber manages over several months) and side effects that patients sometimes need support navigating. If that clinical support is not included in what you are paying, it is worth asking what it costs when you need it. The broader picture of semaglutide payment options covers how private providers structure this differently. For context on what semaglutide is and how it works, the semaglutide overview is a useful read before your first consultation.

There is a practical rhythm to treatment that patients often find reassuring once they are in it. You take your injection once a week, your prescription renews after a clinical review, and the next supply arrives. Some people set a reminder for Thursday morning, a few minutes before the kettle goes on, it becomes part of the week quickly.

How to think about this decision before starting

The decision about whether and how to pay for Wegovy privately is really three decisions folded together: whether you are clinically suitable, which provider offers the right level of clinical oversight for you, and whether the monthly cost is manageable on an ongoing basis. None of those is purely a financial question.

NICE's published guidance on semaglutide for weight management (TA875) is worth reading if you want to understand the clinical basis for treatment and what the evidence says. The trial data behind Wegovy shows clinically meaningful average weight reduction over 68 weeks, but individual results vary and treatment works best alongside dietary changes and increased activity. A prescriber will go through all of this with you at consultation.

If you are considering the newer oral option, the Wegovy weight loss treatment page covers what both the injection and the tablet involve. For questions about travelling with treatment or day-to-day practicalities, the guide to travelling with Wegovy addresses what to expect. And if you want to explore the full range of licensed weight management treatments available through nume, the weight loss treatment overview is a good place to start before you commit to anything.

When you are ready to find out whether you are clinically suitable, a free consultation with one of our prescribers is the natural first step.

Start your free consultation and a GPhC-registered prescriber will review your details the same day.